D.E. Shaw & Co’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-121,286
| Closed | -$3.26M | – | 4626 |
|
|
2022
Q1 | $3.26M | Buy |
121,286
+17,130
| +16% | +$460K | ﹤0.01% | 2050 |
|
|
2021
Q4 | $4.97M | Sell |
104,156
-5,262
| -5% | -$251K | ﹤0.01% | 1678 |
|
|
2021
Q3 | $7.27M | Sell |
109,418
-19,601
| -15% | -$1.3M | 0.01% | 1229 |
|
|
2021
Q2 | $10.1M | Sell |
129,019
-126,910
| -50% | -$9.9M | 0.01% | 1049 |
|
|
2021
Q1 | $24.2M | Buy |
255,929
+161,628
| +171% | +$15.3M | 0.02% | 628 |
|
|
2020
Q4 | $11.5M | Buy |
+94,301
| New | +$11.5M | 0.01% | 926 |
|
|
2020
Q3 | – | Sell |
-3,576
| Closed | -$231K | – | 2880 |
|
|
2020
Q2 | $231K | Buy |
+3,576
| New | +$231K | ﹤0.01% | 2413 |
|
|
2020
Q1 | – | Sell |
-4,241
| Closed | -$264K | – | 2945 |
|
|
2019
Q4 | $264K | Buy |
+4,241
| New | +$264K | ﹤0.01% | 2417 |
|